Trial reportNature human behaviour2026
A cluster-randomized trial of labelled cash transfers for uptake of care for chronic conditions among middle-aged and older adults in Burkina Faso.
Trial report in Nature human behaviour, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-communicable chronic diseases disproportionately affect people living in low- and middle-income countries, with low linkage to care and healthcare utilization identified as contributors to the considerable unmet treatment need in these settings. Here we assess the effect of labelled cash transfers (LCTs) to incentivize clinic-based uptake of care for chronic conditions in rural Burkina Faso (German Clinical Trials Register DRKS00014734). N = 1,242 adults aged 40 years and older with diagnoses of hypertension, hyperlipidaemia and diabetes were randomized to one of three trial arms to receive a high LCT of 1,000 Franc de la Communauté Financière d'Afrique (FCFA) (~US$2), a lower payment of 500 FCFA or no cash transfer. Cash transfers were labelled with an explanation of their intent. The primary trial endpoints of linkage to care and treatment uptake were not found to be significantly affected by LCT receipt. Most secondary endpoints also did not meet significance. The secondary outcome of rates of face-to-face examinations was paradoxically significantly lower in LCT recipient groups than controls; however, this finding should be interpreted with caution.
Indexed as
Identifiers
42010350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.